(Q51685171)

9 April 2018

title

Atriobiventricular pacing improves exercise capacity in patients with heart failure and intraventricular conduction delay. (English)

1 reference

9 April 2018

0 references

Chetan Varma

1

1 reference

9 April 2018

Sanjay Sharma

2

1 reference

9 April 2018

Sam Firoozi

3

1 reference

9 April 2018

William J McKenna

4

1 reference

9 April 2018

Jean-Claude Daubert

5

1 reference

9 April 2018

Multisite Stimulation in Cardiomyopathy (MUSTIC) Study Group

6

1 reference

9 April 2018

language of work or name

English

0 references

publication date

1 February 2003

1 reference

9 April 2018

Journal of the American College of Cardiology

published in

1 reference

9 April 2018

volume

41

1 reference

9 April 2018

issue

4

1 reference

9 April 2018

page(s)

582-588

1 reference

9 April 2018

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902849-8

7 January 2021

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902849-8

7 January 2021

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902849-8

7 January 2021

Successes and failures of current treatment of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902849-8

7 January 2021

Four chamber pacing in dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902849-8

7 January 2021

Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902849-8

7 January 2021

Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902849-8

7 January 2021

Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902849-8

7 January 2021

Effect of multisite pacing on ventricular coordination

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902849-8

7 January 2021

Permanent left ventricular pacing with transvenous leads inserted into the coronary veins

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902849-8

7 January 2021

Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902849-8

7 January 2021

Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902849-8

7 January 2021

Impairment of ventilatory efficiency in heart failure: prognostic impact

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902849-8

7 January 2021

A new method for detecting anaerobic threshold by gas exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902849-8

7 January 2021

Six minute walking test for assessing exercise capacity in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902849-8

7 January 2021

What is the ideal study design for evaluation of treatment for heart failure? Insights from trials assessing the effect of ACE inhibitors on exercise capacity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902849-8

7 January 2021

Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902849-8

7 January 2021

Improvement in exercise tolerance and symptoms of congestive heart failure during treatment with candesartan cilexetil. Symptom, Tolerability, Response to Exercise Trial of Candesartan Cilexetil in Heart Failure (STRETCH) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902849-8

7 January 2021

Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902849-8

7 January 2021

Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902849-8

7 January 2021

Skeletal Muscle Function and Its Relation to Exercise Tolerance in Chronic Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902849-8

7 January 2021

Multisite pacing for end-stage heart failure: early experience

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902849-8

7 January 2021

Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902849-8

7 January 2021

Chronotropic incompetence in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902849-8

7 January 2021

Does the study of anaerobic metabolism give quantitative information on left ventricular dysfunction during exercise?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902849-8

7 January 2021

Central and peripheral components of chronic heart failure: determinants of exercise tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902849-8

7 January 2021

Contribution of peripheral chemoreceptors to ventilation and the effects of their suppression on exercise tolerance in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902849-8

7 January 2021

10.1016/S0735-1097(02)02849-8

Identifiers

DOI

1 reference

9 April 2018

1 reference

9 April 2018